Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma

BACKGROUND: In order to predict long-term prognosis and define individual treatment modalities for patients with oral squamous cell carcinoma (OSCC), more reliable tumor biomarkers are needed during the pretreatment workup period. The present study aimed to identify more reliable immunohistochemical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye-Jin, Kang, Young-Hoon, Lee, Jong-Sil, Byun, June-Ho, Kim, Uk-Kyu, Jang, Si-Jung, Rho, Gyu-Jin, Park, Bong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667499/
https://www.ncbi.nlm.nih.gov/pubmed/26626427
http://dx.doi.org/10.1186/s12903-015-0120-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667499/
https://www.ncbi.nlm.nih.gov/pubmed/26626427
http://dx.doi.org/10.1186/s12903-015-0120-9

Ejemplares similares